FORMALDEHYDE


Synonyms	Dowling's E240 Formaldehyde Formaldehyde solution Formalin Formalinum Formic aldehyde Lysoform NSC-298885 Oxymethylene Paraform Superlysoform Veracur
Status
Molecule Category	Free-form
UNII	1HG84L3525
EPA CompTox	DTXSID7020637


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	WSFSSNUMVMOOMR-UHFFFAOYSA-N
Smiles	C=O
InChI	InChI=1S/CH2O/c1-2/h1H2

Physicochemical Descriptors

Property Name	Value
Molecular Formula	CH2O
Molecular Weight	30.03
AlogP	-0.18
Hydrogen Bond Acceptor	1.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	0.0
Polar Surface Area	17.07
Molecular species	None
Aromatic Rings	0.0
Heavy Atoms	2.0

Cross References

Resources	Reference
ChEBI	16842
ChEMBL	CHEMBL1255
DrugBank	DB03843
DrugCentral	3244
FDA SRS	1HG84L3525
Human Metabolome Database	HMDB0001426
Guide to Pharmacology	4196
KEGG	C00067
PDB	FOR
PharmGKB	PA449703
PubChem	712
SureChEMBL	SCHEMBL268

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).